Nick Corriveau-Lecavalier
Overview
Explore the profile of Nick Corriveau-Lecavalier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolk D, Nelson P, Apostolova L, Arfanakis K, Boyle P, Carlsson C, et al.
Alzheimers Dement
. 2025 Jan;
21(1):e14202.
PMID: 39807681
Limbic predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is highly prevalent in late life and a common co-pathology with Alzheimer's disease neuropathologic change (ADNC). LATE-NC is a slowly progressive, amnestic...
2.
Piura Y, Corriveau-Lecavalier N, Abu Dabrh A, Geschwind M, Brigham T, Day G
J Neurol
. 2024 Dec;
272(1):67.
PMID: 39680209
Background And Objectives: The term rapid progressive dementia (RPD) may be applied to patients who develop dementia within 1 year or complete incapacitation within 2 years of the first symptom...
3.
Corriveau-Lecavalier N, Adams J, Fischer L, Molloy E, Maass A
Brain Commun
. 2024 Nov;
6(6):fcae376.
PMID: 39513091
Neuronal dysfunction in specific brain regions or across distributed brain networks is a known feature of Alzheimer's disease. An often reported finding in the early stage of the disease is...
4.
Corriveau-Lecavalier N, Piura Y, Appleby B, Shir D, Barnard L, Gogineni V, et al.
Ann Clin Transl Neurol
. 2024 Oct;
11(12):3227-3237.
PMID: 39470158
Objective: Prion disease classically presents with rapidly progressive dementia, leading to death within months of diagnosis. Advances in diagnostic testing have improved recognition of patients with atypical presentations and protracted...
5.
Vandebergh M, Ramos E, Corriveau-Lecavalier N, Ramanan V, Kornak J, Mester C, et al.
Neurology
. 2024 Sep;
103(8):e209832.
PMID: 39321401
Background And Objectives: has been proposed as a modifier of disease risk in FTLD-TDP, particularly in pathogenic variant carriers. Furthermore, has been investigated as a disease modifier in the context...
6.
Corriveau-Lecavalier N, Botha H, Graff-Radford J, Switzer A, Przybelski S, Wiste H, et al.
Brain Commun
. 2024 Jul;
6(4):fcae183.
PMID: 39021510
Predominant limbic degeneration has been associated with various underlying aetiologies and an older age, predominant impairment of episodic memory and slow clinical progression. However, the neurological syndrome associated with predominant...
7.
Shir D, Corriveau-Lecavalier N, Graff-Radford J, Machulda M, Knopman D, Petersen R, et al.
Neurocase
. 2024 May;
30(1):1-7.
PMID: 38758704
A research participant was monitored over nearly two decades at Mayo Clinic, undergoing annual neurologic assessments, neuropsychological tests, and multimodal imaging. Initially, he was cognitively normal but developed symptoms consistent...
8.
Vandebergh M, Ramos E, Corriveau-Lecavalier N, Ramanan V, Kornak J, Mester C, et al.
medRxiv
. 2024 Apr;
PMID: 38633784
Background And Objectives: has been proposed as a modifier of disease risk in FTLD-TDP, particularly in mutation carriers. Furthermore, has been investigated as a disease modifier in the context of...
9.
Kouri N, Frankenhauser I, Peng Z, Labuzan S, Boon B, Moloney C, et al.
JAMA Neurol
. 2024 Apr;
81(6):619-629.
PMID: 38619853
Importance: Factors associated with clinical heterogeneity in Alzheimer disease (AD) lay along a continuum hypothesized to associate with tangle distribution and are relevant for understanding glial activation considerations in therapeutic...
10.
Shir D, Corriveau-Lecavalier N, Bermudez Noguera C, Barnard L, Pham N, Botha H, et al.
J Neurol Neurosurg Psychiatry
. 2024 Mar;
95(9):812-821.
PMID: 38514176
Background: Primary progressive aphasia (PPA) defines a group of neurodegenerative disorders characterised by language decline. Three PPA variants correlate with distinct underlying pathologies: semantic variant PPA (svPPA) with transactive response...